SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057785
Filing Date
2024-05-10
Accepted
2024-05-10 16:03:49
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prok-20240331.htm   iXBRL 10-Q 1395673
2 EX-10.5 prok-ex10_5.htm EX-10.5 39220
3 EX-31.1 prok-ex31_1.htm EX-31.1 16082
4 EX-31.2 prok-ex31_2.htm EX-31.2 16064
5 EX-32.1 prok-ex32_1.htm EX-32.1 9330
6 EX-32.2 prok-ex32_2.htm EX-32.2 9343
  Complete submission text file 0000950170-24-057785.txt   7162513

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240331.xsd EX-101.SCH 1174027
69 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240331_htm.xml XML 1229772
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

IRS No.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40560 | Film No.: 24934707
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)